MONENSIN PREMIX DRUG PREMIX

Land: Kanada

Språk: engelska

Källa: Health Canada

Köp det nu

Bipacksedel Bipacksedel (PIL)
25-05-2024
Produktens egenskaper Produktens egenskaper (SPC)
25-05-2024

Aktiva substanser:

MONENSIN (MONENSIN SODIUM)

Tillgänglig från:

BIO AGRI MIX LP

ATC-kod:

QP51AH03

INN (International namn):

MONENSIN

Dos:

200G

Läkemedelsform:

DRUG PREMIX

Sammansättning:

MONENSIN (MONENSIN SODIUM) 200G

Administreringssätt:

ORAL

Enheter i paketet:

15G/50G

Receptbelagda typ:

OTC

Terapeutisk grupp:

CATTLE; GOATS; POULTRY; POULTRY; SHEEP

Terapiområde:

MONENSIN

Produktsammanfattning:

Active ingredient group (AIG) number: 0112512003

Bemyndigande status:

APPROVED

Tillstånd datum:

2020-06-10

Bipacksedel

                                Monensin Premix (BIO AGRI MIX LP)
Label
Label
Use/Dose
BIO AGRI MIX LP
P.O. BOX 399, 11 ELLENS STREET, MITCHELL, ON, N0K 1N0
Telephone:
519-348-9865
Order Desk:
800-265-1763
Technical Information: 519-348-4402
Fax:
519-348-4100
Website:
www.bioagrimix.com
Email:
info@bioagrimix.com
Every effort has been made to ensure the accuracy of the information
published. However, it remains the responsibility of the readers to
familiarize
themselves with the product information contained on the Canada
product label or package insert.
MONENSIN PREMIX
_BIO AGRI MIX_
MONENSIN PREMIX USP
Veterinary Use Only
DIN 02243232
ACTIVE INGREDIENTS:
Monensin (as monensin sodium)
200g/kg
INDICATIONS:
BROILER CHICKENS AND GROWING TURKEYS:
1. As an aid in the prevention of coccidiosis caused by _Eimeria
acervulina, E. mitis, E. necatrix, E. maxima, E. tenella,_ and _E.
brunetti_ in broiler
chickens.
2. As an aid in the prevention of coccidiosis caused by _Eimeria
adenoeides, E. meleagrimitis_ and _E. gallopavonis_ in growing
turkeys.
CATTLE:
1. For improved feed efficiency in beef cattle (steers and heifers)
fed in confinement for slaughter.
2. As an aid in the prevention of coccidiosis caused by _Eimeria
bovis_ and _Eimeria zuernii_. Note to user: Coccidiosis occurs
sporadically in first
lactation dairy heifers, but is not considered a significant disease
in mature dairy cows.
3. For increased rate of weight gain in growing cattle on pasture
(slaughter, stocker and feeder cattle, and beef and dairy replacement
heifers) of
greater than 180 kg (400 lb) body weight.
4. For reduction of milk fat percentage in lactating dairy cows.
5. For minimizing loss of body condition during lactation in dairy
cows.
6. For improving feed efficiency of milk protein production in
lactating dairy cows.
DOSAGE AND ADMINISTRATION:
Important - must be thoroughly mixed in feeds before use.
BROILER CHICKENS AND GROWING TURKEYS:
Thoroughly mix 500 g (0.50 kg) of MONENSIN premix in one metric tonne
(1000 kg) of feed to provide monensin at 100 g monensin activity per

                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                #8301
Page 1
of
5
Issue date
18-Mar-2013
MATERIAL SAFETY DATA SHEET
.
1. PRODUCT AND COMPANY IDENTIFICATION
space
PRODUCT NAME
MONENSIN PREMIX
space
CAS #
Mixture
space
PRODUCT USE
Medicated Feed Premix
space
MANUFACTURER
Bio Agri
Mix LP
P.O. Box 399
Mitchell, ON N0K 1N0 CA
Phone: (519) 348-9865
Emergency Phone: 1-613-996-6666 (CANUTEC)
.
2. HAZARDS IDENTIFICATION
space
EMERGENCY OVERVIEW
CAUTION
MAY CAUSE EYE IRRITATION.
MAY CAUSE SKIN IRRITATION.
space
POTENTIAL SHORT TERM HEALTH EFFECTS
ROUTES OF EXPOSURE
Eye, Skin contact, Skin absorption,
Inhalation, Ingestion.
space
space
space
space
space
EYES
May cause irritation.
SKIN
May cause irritation. May be absorbed through the skin.
INHALATION
Dusts of this product may cause irritation of the nose, throat, and
respiratory tract.
INGESTION
May cause stomach distress, nausea or vomiting.
TARGET ORGANS
Eyes. Respiratory system. Skin.
space
CHRONIC EFFECTS
Prolonged or repeated exposure can cause drying, defatting and
dermatitis.
space
SIGNS AND SYMPTOMS
Symptoms may include redness, oedema, drying, defatting and cracking
of the skin.
Symptoms of overexposure may be headache, dizziness, tiredness, nausea
and
vomiting.
space
POTENTIAL ENVIRONMENTAL
EFFECTS
Not available
.
3. COMPOSITION/INFORMATION ON INGREDIENTS
space
INGREDIENT(S)
Monensin, monosodium salt
Calcium sulfate dihydrate
CAS #
22373-78-0
10101-41-4
PERCENT
10 - 30
10 - 30
.
4. FIRST AID MEASURES
space
FIRST AID PROCEDURES
EYE CONTACT
space
Immediately flush with cool
water.
Remove contact lenses, if applicable, and continue
flushing for 15 minutes.
Obtain medical
attention if irritation develops or persists.
space
space
space
SKIN CONTACT
Brush away excess of dry material.
Immediately flush with cool
water for 15 minutes
while removing contaminated clothing and shoes. Discard or wash well
before reuse.
Obtain medical
attention if irritation persists.
INHALATION
If symptoms develop move victim to fresh air.
If symptoms persist, obtain medical
attention.
INGESTION
Do not induce vomiting. Never give anything 
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel franska 25-05-2024

Sök varningar relaterade till denna produkt